Literature DB >> 3288028

Campylobacter pylori antibodies in humans.

G I Perez-Perez1, B M Dworkin, J E Chodos, M J Blaser.   

Abstract

STUDY
OBJECTIVE: To determine the diagnostic value of assays to measure serum antibodies to Campylobacter pylori, and to use these assays to determine the prevalence of C. pylori infection in a healthy population.
DESIGN: A survey of patients having endoscopies for upper gastrointestinal symptoms, patients with other gastrointestinal illnesses, and healthy controls.
SETTING: Outpatients attending endoscopy suites in two university-affiliated medical centers. PATIENTS: One hundred and twenty patients who had gastroduodenoscopies, 61 patients with lower intestinal illnesses, and 166 healthy controls. INTERVENTION: Assay to detect serum IgA, IgG, and IgM antibodies specific for C. pylori.
MEASUREMENTS AND MAIN RESULTS: Absorption with other gram-negative pathogens showed that IgG and IgA assays, but not IgM assays, were specific for C. pylori. In patients in whom C. pylori had been isolated and who had gastritis diagnosed by histologic methods, significantly higher mean IgA and IgG levels were seen compared with patients without demonstrable C. pylori or gastritis. The sensitivity and specificity of a positive value in both IgA and IgG assays were more than 93%. Among healthy persons, IgG and IgA antibodies were rarely seen in patients less than 20 years old, but antibody prevalence progressed with age, reaching 50% in patients more than 60 years old. High IgA and IgG levels to C. pylori in five persons tested remained stable for more than 1 year, suggesting the organism persists for at least that period. In 61 patients with acute bacterial enteritis, acute pancreatitis, Crohn disease, or ulcerative colitis, prevalence of antibodies to C. pylori was consistent with age and unrelated to current disease.
CONCLUSIONS: Campylobacter pylori infection, which is highly associated with active gastritis, may be diagnosed by serologic assay. Acquisition of infection begins in adult life, and prevalence increases with age.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3288028     DOI: 10.7326/0003-4819-109-1-11

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  157 in total

1.  T-cell, antibody, and cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection.

Authors:  S A Sharma; G G Miller; R A Peek; G Pérez-Pérez; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Helicobacter pylori heat shock protein A: serologic responses and genetic diversity.

Authors:  E K Ng; S A Thompson; G I Pérez-Pérez; I Kansau; A van der Ende; A Labigne; J J Sung; S C Chung; M J Blaser
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection.

Authors:  Y Glupczynski; A Burette; H Goossens; C DePrez; J P Butzler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

Review 4.  Helicobacter pylori.

Authors:  B Drumm
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

Review 5.  Gastritis.

Authors:  R G Strickland
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection.

Authors:  J E Crabtree; T M Shallcross; R V Heatley; J I Wyatt
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

7.  Seroprevalence of helicobacter pylori infection in couples.

Authors:  G I Perez-Perez; S S Witkin; M D Decker; M J Blaser
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

8.  Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant.

Authors:  S A Sharma; G G Miller; G I Perez-Perez; R S Gupta; M J Blaser
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

9.  Serological diagnosis of Helicobacter pylori--evaluation of four tests in the presence or absence of non-steroidal anti-inflammatory drugs.

Authors:  A S Taha; J Reid; P Boothmann; C G Gemmell; F D Lee; R D Sturrock; R I Russell
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

10.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.